Pharmafile Logo

Peter Impey

- PMLiVE

2017 Trends Reports

GSW and InVentiv Health Communications are pleased to release the 6th installment of the Trends report series, consisting of four reports: Consumer, Digital, Communications and Healthcare

Syneos Health®

Bristol-Myers Squibb (BMS) building

Opdivo drives growth at BMS, but US sales slow down

Sales beginning to lose momentum despite new indications bringing in $1.3bn for Q4

- PMLiVE

NICE U-turn on Imbruvica sees the leukaemia therapy backed for NHS use

Institute reverses its initial verdict on Janssen's oncology treatment

Celgene building

Celgene pays $300m upfront for immunology start-up Delinia

Broadens its pipeline with autoimmune disease candidate due to start trials in 2018

- PMLiVE

The reality of real-world evidence

Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice

- PMLiVE

AXON Communications boosts senior team

Sola Neunie, Simonetta Ballali and Andy Scott join

- PMLiVE

Takeda UK & Ireland appoints market access director

Peter Wheatley Price brings experience from GSK, Janssen and Boehringer Ingelheim

- PMLiVE

AbbVie takes anti-tau drug into phase II for Alzheimer’s

Also testing antibody in rare condition PSP, for which FDA has awarded fast-track designation

Actelion HQ Switzerland

J&J agrees $30bn deal to acquire Actelion

Swiss biotech to retain control of early-stage pipeline as J&J takes minority stake in R&D spin-out

Smart connections with a human touch

Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support...

Blue Latitude Health

- PMLiVE

The digital race: Eight ways to get up-to-speed

The festive season is over, so why does analysis of pharma’s digital progress feel like a Christmas repeat of Groundhog Day? Here are eight ideas to stop next year feeling like...

- PMLiVE

GSK appoints president of global pharmaceuticals

Luke Miels joins from AstraZeneca

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links